Osaka, Japan, June27, 2019, --- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ('Takeda') today announced new assignment of Directors. The details are as follows;
1.New assignment of Non-Audit and Supervisory Committee Directors effective June 27, 2019;
Name | Category | Role | |
Christophe Weber | Internal | Existing |
Representative Director, |
Masato Iwasaki | Internal | Existing | Director, President, Japan Pharma Business Unit |
Andrew Plump | Internal | Existing | Director, President, Research & Development |
Constantine Saroukos | Internal | New | Director, Chief Financial Officer |
Masahiro Sakane | External | Existing | External Director, Chair of the Board Meeting |
Olivier Bohuon | External | Existing | External Director |
Jean-Luc Butel | External | New | External Director |
Ian Clark | External | Existing | External Director |
Yoshiaki Fujimori | External | Existing | External Director |
Steven Gillis | External | Existing | External Director |
Shiro Kuniya | External | New | External Director |
Toshiyuki Shiga | External | Existing | External Director |
2.New assignment of Audit and Supervisory Committee Directors effective June 27, 2019;
Name | Category | Role | |
Yasuhiko Yamanaka | Internal | - | Director, Audit & Supervisory Committee member |
Koji Hatsukawa | External | - | External Director, Chairperson of Audit & Supervisory Committee |
Emiko Higashi | External | New | External Director, Audit & Supervisory Committee member |
Michel Orsinger | External | New | External Director, Audit & Supervisory Committee member |
Yasuhiko Yamanaka and Koji Hatsukawa are within their 2-year tenure of Audit and Supervisory Committee Director, and were not subjects for reelection this year.
3.New assignment of Compensation committee and Nomination committee effective June 27, 2019;
- Compensation committee : Emiko Higashi (Chair), Olivier Bohuon, Ian Clark, Yoshiaki Fujimori
- Nomination committee : Masahiro Sakane (Chair), Jean-Luc Butel, Steven Gillis,
Toshiyuki Shiga, Michel Orsinger, Christophe Weber (Observer)
Media Contact:
Kazumi Kobayashi
kazumi.kobayashi@takeda.com
+81 (0) 3-3278-2095
Attachments
- Original document
- Permalink
Disclaimer
Takeda Pharmaceutical Co. Ltd. published this content on 28 June 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 June 2019 05:40:03 UTC